Oppenheimer Asset Management Inc. Merck & Co., Inc. Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 424,793 shares of MRK stock, worth $41.7 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

424,793

Previous 382,741 10.99%

Holding current value

$41.7 Million

Previous $47.4 Million 1.81%

% of portfolio

0.6%

Previous 0.62%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$111.15 - $128.97 $4.67 Million - $5.42 Million	42,052 Added 10.99%	424,793 $48.2 Million
Q2 2024 Aug 08, 2024	BUY	$123.8 - $132.96 $6.82 Million - $7.32 Million	55,085 Added 16.81%	382,741 $47.4 Million
Q1 2024 May 06, 2024	SELL	$113.24 - $131.95 $8.73 Million - $10.2 Million	-77,096 Reduced 19.05%	327,656 $43.2 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $468,642 - $509,995	-4,678 Reduced 1.14%	404,752 $44.1 Million
Q3 2023 Nov 07, 2023	SELL	$102.95 - $114.33 $1.84 Million - $2.04 Million	-17,857 Reduced 4.18%	409,430 $42.2 Million
Q2 2023 Aug 02, 2023	SELL	$108.61 - $118.38 $1.16 Million - $1.26 Million	-10,685 Reduced 2.44%	427,287 $49.3 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $592,625 - $661,249	-5,757 Reduced 1.3%	437,972 $46.6 Million
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $1.46 Million - $1.87 Million	-16,660 Reduced 3.62%	443,729 $49.2 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $3.65 Million - $4.1 Million	43,168 Added 10.35%	460,389 $39.7 Million
Q2 2022 Aug 08, 2022	BUY	$83.49 - $94.64 $675,350 - $765,542	8,089 Added 1.98%	417,221 $38 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $1.3 Million - $1.45 Million	17,645 Added 4.51%	409,132 $33.6 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $883,767 - $1.11 Million	12,227 Added 3.22%	391,487 $30 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $1.3 Million - $1.43 Million	18,170 Added 5.03%	379,260 $28.5 Million
Q2 2021 Aug 03, 2021	BUY	$70.31 - $77.77 $2.97 Million - $3.28 Million	42,193 Added 13.23%	361,090 $28.1 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $652,310 - $768,355	9,473 Added 3.06%	318,897 $24.6 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $1.54 Million - $1.71 Million	-21,450 Reduced 6.48%	309,424 $25.3 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $675,231 - $765,379	9,227 Added 2.87%	330,874 $27.4 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $1.43 Million - $1.62 Million	-20,262 Reduced 5.93%	321,647 $24.9 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $1.94 Million - $2.69 Million	30,660 Added 9.85%	341,909 $26.3 Million
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $3.97 Million - $4.48 Million	-51,220 Reduced 14.13%	311,249 $28.3 Million
Q3 2019 Oct 31, 2019	SELL	$76.08 - $82.93 $578,588 - $630,682	-7,605 Reduced 2.05%	362,469 $30.5 Million
Q2 2019 Aug 09, 2019	BUY	$69.84 - $81.59 $233,964 - $273,326	3,350 Added 0.91%	370,074 $31 Million
Q1 2019 Apr 24, 2019	SELL	$69.58 - $79.36 $252,436 - $287,918	-3,628 Reduced 0.98%	366,724 $30.5 Million
Q4 2018 Jan 30, 2019	BUY	$65.24 - $75.71 $1.11 Million - $1.29 Million	17,065 Added 4.83%	370,352 $28.3 Million
Q3 2018 Oct 26, 2018	BUY	$57.69 - $67.84 $38,883 - $45,724	674 Added 0.19%	353,287 $25.1 Million
Q2 2018 Aug 10, 2018	BUY	$50.83 - $59.72 $2.77 Million - $3.25 Million	54,467 Added 18.27%	352,613 $21.4 Million
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $374,708 - $435,518	7,353 Added 2.53%	298,146 $16.2 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $17.1 Million - $18.4 Million	290,793	290,793 $18.6 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Merck & Co., Inc. Transaction History